Read + Share
Amedeo Smart
Independent Medical Education
Critchlow S, Bullement A, Crabb S, Jones R, et al. Cost-effectiveness analysis for avelumab first-line maintenance treatment of advanced urothelial carcinoma in Scotland. Future Oncol 2024;20:459-470.PMID: 37529943
Email
LinkedIn
Facebook
Twitter
Privacy Policy